EUVIMEDEUVIMED entdecken
Crossref

Novel Triazole‐Linked Indole Derivatives as Potent Soluble Epoxy Hydrolase Inhibitors With Promising Anticancer Activity

Vijaykumar D Nimbarte, Shreya S Sonak, Sharda A Ishwarkar, Bharat Rathod, Saiprem Nehlani

Chemical Biology & Drug Design · 2025

DOI: 10.1111/cbdd.70164 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Chemical Biology & Drug Design, 2025. Verfasst von Vijaykumar D Nimbarte und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Birla Institute of Technology and Science (BITS) Pilani, Medchal, Telangana, India. Hauptthemen laut MEDLINE: Epoxide Hydrolases, Triazoles, Indoles, Antineoplastic Agents. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 10 Literaturangaben. Gefördert von: NFSG H0946 BITS Grant.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

A novel series of triazole‐linked indole derivatives was designed, synthesized, and evaluated as soluble epoxide hydrolase inhibitors (sEHIs) for their potential anticancer activity. These compounds exhibit strong binding affinity within the hydrophobic pockets of sEH, with compounds 9a and 9b emerging as the most potent inhibitors, achieving IC₅₀ values of 0.270 ± 0.014 nM and 0.358 ± 0.03 nM, respectively, in vitro. In addition, both compounds display significant cytotoxic activity against HeLa cells, with IC₅₀ values of 5.366 ± 0.91 μM and 5.686 ± 0.73 μM, respectively. Molecular docking studies, using the 1ZD5 crystal structure, reveal key hydrogen bond interactions analogous to those observed with 12‐(3‐adamantan‐1‐yl‐ureido)‐dodecanoic acid (AUDA), providing mechanistic insights into their inhibitory activity. Structure–activity relationship (SAR) analysis further informs the rational optimization of these derivatives for enhanced potency. Overall, these findings highlight triazole‐linked indole derivatives as promising lead candidates for the development of sEH‐targeted anticancer therapeutics.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Epoxide HydrolasesTriazolesIndolesAntineoplastic AgentsEnzyme InhibitorsHumansStructure-Activity RelationshipMolecular Docking SimulationHeLa Cells

Stichwörter der Autor:innen

anticancernitro‐indolespainsoluble epoxy hydrolasetriazoles

Substanzen

Epoxide HydrolasesTriazolesIndolesAntineoplastic AgentsEnzyme Inhibitors

Autor:innen und Institutionen

  • Department of Pharmacy, Birla Institute of Technology and Science (BITS) Pilani, Medchal, Telangana, India.
  • Institute for Organic Chemistry and Chemical Biology Center for Biomolecular Magnetic Resonance (BMRZ) Goethe University Frankfurt Max-von-Laue-Straße 7, Frankfurt am Main, Germany.
  • Department of Chemistry, Govindrao Wanjari College of Engineering and Technology, Nagpur, India.

Förderung

  • NFSG H0946 BITS Grant

Zitieren

APA

Nimbarte, V. D., Sonak, S. S., Ishwarkar, S. A., Rathod, B., & Nehlani, S. (2025). Novel Triazole‐Linked Indole Derivatives as Potent Soluble Epoxy Hydrolase Inhibitors With Promising Anticancer Activity. Chemical Biology & Drug Design. https://doi.org/10.1111/cbdd.70164

Vancouver

Nimbarte VD, Sonak SS, Ishwarkar SA, Rathod B, Nehlani S. Novel Triazole‐Linked Indole Derivatives as Potent Soluble Epoxy Hydrolase Inhibitors With Promising Anticancer Activity. Chemical Biology & Drug Design. 2025. doi:10.1111/cbdd.70164

BibTeX
@article{Nimbarte2025,
  author = {Nimbarte, Vijaykumar D and Sonak, Shreya S and Ishwarkar, Sharda A and Rathod, Bharat and Nehlani, Saiprem},
  title = {Novel Triazole‐Linked Indole Derivatives as Potent Soluble Epoxy Hydrolase Inhibitors With Promising Anticancer Activity},
  journal = {Chemical Biology & Drug Design},
  year = {2025},
  doi = {10.1111/cbdd.70164}
}
Kostenlos starten →